Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner

Yinxia Feng1, Zhijun Wang1, Zelin Hao2

  • 1Department of Laboratory Medicine, Xing'an League People's Hospital, Xing'an League, Ulanhot, Inner Mongolia, China (mainland).

Insights

Gram-negative bacteria, particularly Escherichia coli and Klebsiella pneumoniae, are the main causes of bloodstream infections in Ulanhot. High drug resistance in strains like Acinetobacter baumannii necessitates urgent surveillance and strategic antibiotic use.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Bloodstream infections (BSIs) pose a significant health threat due to their potential lethality and systemic impact.
  • Understanding pathogen distribution and antimicrobial susceptibility is crucial for effective BSI management.

Purpose of the Study:

  • To determine the drug sensitivity profiles of pathogens causing bloodstream infections.
  • To analyze the distribution of these pathogens in Ulanhot, Inner Mongolia.

Main Methods:

  • Analysis of 2498 blood culture-positive samples collected between 2017 and 2021.
  • Identification of pathogens and drug sensitivity testing using instrument methods, paper diffusion, and Epsilometer test (E-test).
  • Data analysis using WHONET 5.6 software for microbial distribution and resistance patterns.

Main Results:

  • Gram-negative bacteria (62.45%) predominated, with Escherichia coli (35.15%) and Klebsiella pneumoniae (15.73%) as the most frequent pathogens.
  • High resistance rates were observed for methicillin-resistant strains to penicillin G (80.87%-100.00%) and erythromycin (91.16%-97.28%).
  • Acinetobacter baumannii exhibited higher drug resistance than Pseudomonas aeruginosa (resistance <30.00%).

Conclusions:

  • Gram-negative bacteria, specifically E. coli and K. pneumoniae, are the leading causes of BSIs in Ulanhot.
  • Increasing antimicrobial resistance, especially in Acinetobacter baumannii, demands enhanced surveillance and judicious antibiotic stewardship.
  • Preserving antibiotic efficacy is critical for future treatment success.